Product Program year 2023 Source: CMS Open Payments

Prehevbrio

Drug Vaccine

Open in the dashboard

General payments

$57,157

2,588 payments

Research payments

$71,895

5 payments

Through program year 2023, $57,157 in general payments and $71,895 in research payments were reported against Prehevbrio (Vaccine).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2023 Research $18,975 2
2022 General $57,157 2,588
2022 Research $52,920 3

Breakdown

Who paid General payments · program year 2022
  1. VBI Vaccines (Delaware) Inc. $57,157 2,588 payments
Top recipients General payments · program year 2022
  1. Mauricio Lisker Melman Gastroenterology · Saint Louis, MO $1,904 3% · 2 payments
  2. Anthony Martinez Internal Medicine · Buffalo, NY $1,810 3% · 1 payment
  3. Paul Gaglio Transplant Hepatology · Newark, NJ $1,810 3% · 1 payment
  4. Coleman Smith Gastroenterology · Saint Paul, MN $1,810 3% · 1 payment
  5. Naim Alkhouri Gastroenterology · Westlake, OH $1,810 3% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Family Medicine $15,933 28% · 671 practitioners
  2. Internal Medicine $10,507 18% · 348 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $8,036 14% · 366 practitioners
  4. Gastroenterology Internal Medicine $6,041 11% · 27 practitioners
  5. Physician Assistant $3,766 7% · 177 practitioners

The top 5 of 66 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. New York $7,605 13% · 153 recipients
  2. Texas $6,818 12% · 206 recipients
  3. California $5,728 10% · 182 recipients
  4. Georgia $3,121 5% · 127 recipients
  5. Illinois $2,890 5% · 96 recipients

The top 5 of 42 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

2,588 general · 5 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record